Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication

被引:0
|
作者
McAllister, Peter [1 ]
Dodick, David [2 ]
Cohen, Joshua [3 ]
Yang, Ronghua [3 ]
Yeung, Paul [3 ]
Campos, Verena Ramirez [3 ]
机构
[1] New England Inst Neurol & Headache, Stamford, CT USA
[2] Mayo Clin, Dept Neurol, Phoenix, AZ USA
[3] Teva Pharmaceut, Frazer, PA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1.10-011
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Efficacy of fremanezumab in migraine patients who have failed at least one prior migraine preventive medication
    McAllister, Peter
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [2] Impact of fremanezumab on response rates, migraine days, and acute medication use in patients with chronic migraine who have failed at least one prior migraine preventive medication
    Silberstein, Stephen D.
    Ailani, Jessica
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [3] Impact of Fremanezumab on Response Rates, Migraine Days, and Acute Medication Use in Patients with Chronic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication
    Silberstein, Stephen
    Ailani, Jessica
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul P.
    Campos, Verena Ramirez
    [J]. NEUROLOGY, 2019, 92 (15)
  • [4] Efficacy of fremanezumab in migraine patients who have failed at least one prior migraine preventive medication (vol 19, pg O40, 2018)
    McAllister, Peter
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [5] Impact of fremanezumab on response rates, acute medication use, and disability in patients with episodic migraine who have failed at least one prior migraine preventive medication
    Winner, Paul K.
    Singh, Rashmi B. Halker
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [6] Impact of Fremanezumab on Response Rates, Acute Medication Use, and Disability in Patients With Episodic Migraine Who Have Failed at Least One Prior Migraine Preventive Medication
    Winner, Paul
    Singh, Rashmi Halker
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul
    Campos, Verena Ramirez
    [J]. NEUROLOGY, 2019, 92 (15)
  • [7] Impact of fremanezumab on response rates, acute medication use, and disability in patients with episodic migraine who have failed at least one prior migraine preventive medication (vol 19, 119, 2018)
    Winner, Paul K.
    Singh, Rashmi B. Halker
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [8] Long-term efficacy of fremanezumab in chronic and episodic migraine patients who failed at least one prior migraine preventive medication: results of a 1-year study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Blaiss, Cory
    [J]. CEPHALALGIA, 2019, 39 : 36 - 37
  • [9] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, P. K.
    Freeman, M. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 118 - 119
  • [10] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Ortega, Mario
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S168 - S169